VRVenkatasubramanian Ramasubramanian

Venkatasubramanian Ramasubramanian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Venkatasubramanian Ramasubramanian has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A strategic approach to regulating new antimicrobials

    by Shilpi Malhotra, Nitin Bansal, V Ramasubramanian, Veeraraghavan Balaji, Leena Menghaney, Kamini Walia

    Antimicrobial resistance (AMR) is a major challenge for healthcare systems worldwide, including India, where the emergence of resistance to antibiotics, including last resort antibiotics in India, is alarming. Data from the Indian Council of Medical Research (ICMR) AMR surveillance network highlights rising antibiotic resistance rates, with Klebsiella pneumoniae showing 62.3% resistance to carbapenem (specifically meropenem). […]


  • Open Access

    Clinical Utility of Blood Culture Identification 2 Panel in Flagged Blood Culture Samples from the Intensive Care Unit of a Tertiary Care Hospital

    by Ram Gopalakrishnan, Nandini Sethuraman, Panchatcharam S Nambi, Yamunadevi Ramanathan, Chitra Chandran, Vashemane K Vineeth, Venkatasubramanian Ramasubramanian

    Background: The availability of rapid diagnostic platforms for positive blood cultures has accelerated the speed at which the clinical microbiology laboratory can identify the causative organism and facilitate early appropriate antimicrobial therapy. There is a paucity of data regarding the clinical utility of the blood culture identification 2 (BCID2) panel test and its correlation with phenotypic drug susceptibility testing (DST) in flagged blood culture bottles from intensive care units (ICUs) in countries such as India, which have high rates of multidrug-resistant gramnegative bacteria (MDR-GNB). Materials and methods: We conducted a retrospective observational study in a tertiary care ICU on 200 patients above 18 years of age in whom a BCID2 test was ordered when blood cultures flagged positive. Results: We found 99% concordance between BCID2 and cultures in the identification of bacteria and yeasts and 96.5% concordance between phenotypic and genotypic DST. Furthermore, BCID2 was available about 1.5 days earlier than conventional ID and DST and played a key role in tailoring antimicrobials in 82.5% of the patients. Polymyxin-based therapy was discontinued earlier after an empiric dose in 138 patients (69%) based on BCID2 reports. Conclusion: In critically ill patients with monomicrobial bacteremia, BCID2 rapidly identifies bacteria and antimicrobial resistance (AMR) genes and is significantly faster than conventional culture and sensitivity testing. Antibiotics were escalated in more than a third of patients and de-escalated in almost a fifth on the same day. We recommend that all ICUs routinely incorporate the test in their antibiotic decision-making process and in antimicrobial stewardship.


  • Open Access

    Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae

    by Ram Gopalakrishnan, V Ramasubramanian, Nagarajan Ramakrishnan, Nandini Sethuraman, Surendran Rajendran, Anil Tarigopula, D Suresh Kumar, P Senthur Nambi, Chitra Chandran

    Rapid molecular diagnostics to predict carbapenem resistance well before the availability of routine drug sensitivity testing (DST) can serve as an antimicrobial stewardship tool in the context of high rates of Carbapenem-resistant Enterobacteriaceae (CRE). A retrospective observational study of patients more than 18 years of age on whom Xpert Carba-R (FDA approved for rectal swab specimen) was done on gram-negative bacteria (GNB) flagged blood culture samples, in an Indian intensive care unit between January 2015 and November 2018. We analyzed the performance of Xpert Carba-R in comparison with routine DST. A total of 164 GNBs were isolated from 160 patients. Klebsiella pneumoniae and Escherichia coli were the predominant isolates. Carba-R was positive in 35.36% of samples and 45.34% were carbapenem-resistant (CR) on routine DST. The distribution of the CR gene was: Oxacillinase (OXA) (50%), NDM (32.7%) followed by OXA and NDM co-expression (15.51%). The sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, positive predictive value, and negative predictive value of Carba-R were 90.74, 93.15, 13.25, 0.10, 83.58 and 96.31% for Enterobacteriaceae. The median time to obtain the Carba-R report was 30 hours 34 minutes vs 74 hours and 20 minutes for routine DST. Based on the Carba-R report, 9.72% of patients had escalation and 27.08% had de-escalation of antibiotics. Xpert Carba-R serves as a rapid diagnostic tool for predicting carbapenem resistance in intensive care unit patients with bacteremia caused by Enterobacteriaceae. Rajendran S, Gopalakrishnan R, Tarigopula A, Kumar DS, Nambi PS, Sethuraman N, et al. Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae. Indian J Crit Care Med 2023;27(9):655–662.


  • Effect of Allium sativum bulb extracts as feed additives on the immunological, enzymological, biochemical and growth parameters of Cirrhinus mrigala

    by Dhanalakshmi P, Ragunath C, Ramasubramanian V

    The present work was done to test the effect of (A. sativum Linn.) garlic bulb extracts on the immunological, enzymological, biochemical and growth parameters of (C. mrigala Ham.) Indian major carp fingerlings. Five experimental diets namely control, petroleum ether, toluene, ethyl acetate and methanol extract mixed feeds (0.10 %) were prepared and the fishes were fed with them for two months. The results indicated that the oral administration of the extracts led to desirable changes in immunological (superoxide anion production, bactericidal activity and lysozyme activity), enzymological(aspartate transaminase, alanine transaminase and alkaline phosphatise), biochemical (blood glucose, total protein, albumin, globulin, cholesterol and triglycerides)and growth (weight gain%, specific growth rate (SGR) and feed conversion ratio (FCR) parameters. Based on the findings, it could be derived that A. sativum bulb extracts prepared using different solvents; especially the 0.10 %/kg supplemented feed additives enhance the immunity and growth of Indian major carp fingerlings.